Specifically, we targeted three representative mitotic regulators, i.e., BUB1, CHEK1, and PLK1, using selective small-molecule inhibitors and evaluated their effects on BC cell migration and invasion through multiple complementary assays. The gene discussed is PLK1; the disease is breast cancer.